Also interesting
GMP certification for Exothera further extends its viral vector manufacturing capacity
Exothera achieves GMP certification and extends its facilities by a further 2,100 m² (22,600 ft²) production bringing the total capacity to 8,600 m² (92,570 ft²) for viral vector development and manufacturing...
Univercells writes a new biomanufacturing chapter with Africa
Discover how Belgian biotech company Univercells Group intends to make vaccines accessible for everyone in Africa.
GSK invests €250 million in new vaccines manufacturing unit in Belgium
GSK Belgium is building a new center of excellence for the production of freeze-dried vaccines.